A total of 255 subjects have been enrolled, which exceeds the goal of 250 subjects that were planned for participation. The National Institute of Neurological Disorders and Stroke
After the respective agreement, both Proteus and Boston Children’s Hospital will remain as key members of the collaboration steering committee. The agreement includes about $85m in upfront and
SYN-004 is designed to degrade certain intravenous (IV) beta-lactam antibiotics within the gastrointestinal (GI) tract and maintain the natural balance of the gut microbiome for the prevention of
Resunab is a new synthetic oral drug that has the potential to treat chronic inflammation and fibrosis. Systemic sclerosis causes fibrosis of skin and internal organs, affecting predominately
Under the deal, OA Centers of America will include Gensco’s patented Transdermal products (SpeedGel Rx and LiDORx) as an option to show improved patient outcomes and economic value
The results showed patients with relapsed/refractory CLL taking venetoclax in combination with rituximab, had an overall response rate (ORR) of 84%. In addition, six patients stopped venetoclax after
Currently, the company is carrying out a multicenter, randomized, placebo-controlled Phase II clinical trial to evaluate the efficacy and safety of SER-109 in prevention of recurrent CDI. The
The deal, facilitated by J&J Innovation, will see the two firms jointly develop and commercialize RNA-based drug products to treat specified diseases using Arcturus’ UNA Oligomer chemistry and
PADAC has recommended the drug through a unanimous voting of 14 to zero, supporting the biologics licence application (BLA) for mepolizumab as an add-on maintenance treatment for severe
Around 60 individuals will be included in this multi-center, randomized, double-blind, placebo-controlled, two arm, parallel group Phase II trial of ADS-5102. During the trial, all patients will be
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.